Clinical Trials Arena· GlobalData Healthcare·· 18 小时前AI 评分13
ESMO26：Intismeran 在辅助治疗黑色素瘤中树立新标杆
ESMO26: Intismeran sets new benchmark in adjuvant melanoma
AI 导读
ESMO26 会议上，Intismeran 在辅助治疗黑色素瘤中树立新标杆。原文未披露具体临床数据、样本量及终点数值。
正文 · 原文
Unlock FREE Access to Premium Content
Discover exclusive forecasts, analyst insights, and in-depth clinical trials industry analysis across drug development, clinical research, and trial innovation.
With a free Clinical Trials Arena profile, you can:
- Access exclusive analyst commentary and expert insights
- View premium forecasts and data-driven clinical trial intelligence
- Stay up to date with clinical trial news, regulatory updates, and industry trends
- Receive alerts when new premium content is published
Unlock free access
Already have an account? Login here
Powered by
来源：Clinical Trials Arena · clinicaltrialsarena.com